First Header Logo Second Header Logo

Connection

David Caudell to Doxorubicin

Back to Details
This is a "connection" page, showing publications David Caudell has written about Doxorubicin.
David Caudell
Connection Strength
0.035
Doxorubicin
  1. Alexander PM, Caudell DL, Kucera GL, Pladna KM, Pardee TS. The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia. PLoS One. 2017; 12(6):e0179798.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.